List of bibliographic references
Number of relevant bibliographic references: 17.
| Ident. | Authors (with country if any) | Title |
|---|
| 000084 (2020) |
Matthew Zirui Tay [Singapour] ; Chek Meng Poh [Singapour] ; Laurent Rénia [Singapour] ; Paul A. Macary [Singapour] ; Lisa F. P. Ng [Singapour, Royaume-Uni] | The trinity of COVID-19: immunity, inflammation and intervention |
| 000089 (2020) |
Jacob J. Adashek [États-Unis] ; Shumei Kato [États-Unis] ; Scott M. Lippman [États-Unis] ; Razelle Kurzrock [États-Unis] | The paradox of cancer genes in non-malignant conditions: implications for precision medicine |
| 000097 (2020) |
Weiyi Tan ; Jamil Aboulhosn | The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease |
| 000172 (2020) |
Di Mauro Gabriella ; Scavone Cristina ; Rafaniello Concetta ; Rossi Francesco ; Capuano Annalisa | SARS-Cov-2 infection: response of human immune system and possible implications for the rapid test and treatment |
| 000214 (2020) |
Alyson W. Wong [Canada] ; Christopher J. Ryerson [Canada] ; Sabina A. Guler [Suisse] | Progression of fibrosing interstitial lung disease |
| 000329 (2020) |
David R. Goldsmith ; Mark Hyman Rapaport | Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits |
| 000331 (2020) |
Anne Y. Liu [États-Unis] | Infectious Implications of Interleukin-1, Interleukin-6, and T Helper Type 2 Inhibition. |
| 000336 (2020) |
Christophe Richez [France] ; Estibaliz Lazaro [France] ; Maël Lemoine [France] ; Marie-Elise Truchetet [France] ; Thierry Schaeverbeke [France] | Implications of COVID-19 for the management of patients with inflammatory rheumatic diseases |
| 000337 (2020) |
Christophe Richez [France] ; Estibaliz Lazaro [France] ; Maël Lemoine [France] ; Marie-Elise Truchetet [France] ; Thierry Schaeverbeke [France] | Implications du COVID-19 pour la prise en charge des rhumatismes inflammatoires chroniques☆ |
| 000344 (2020) |
Sadaf Atiqi [Pays-Bas] ; Femke Hooijberg [Pays-Bas] ; Floris C. Loeff [Pays-Bas] ; Theo Rispens [Pays-Bas] ; Gerrit J. Wolbink [Pays-Bas] | Immunogenicity of TNF-Inhibitors |
| 000446 (2020) |
Danila Gurgone [Royaume-Uni, Italie] ; Lucy Mcshane [Royaume-Uni] ; Charles Mcsharry [Royaume-Uni] ; Tomasz J. Guzik [Royaume-Uni, Pologne] ; Pasquale Maffia [Royaume-Uni, Italie] | Cytokines at the Interplay Between Asthma and Atherosclerosis? |
| 000451 (2020) |
Yue Zhang ; Qianhao Xu ; Zhuoyan Sun ; Lei Zhou | Current targeted therapeutics against COVID-19: based on first-line experience in china |
| 000484 (2020) |
Martina Pennisi [États-Unis, Italie] ; Tania Jain [États-Unis] ; Bianca D. Santomasso [États-Unis] ; Elena Mead [États-Unis] ; Kitsada Wudhikarn [États-Unis, Thaïlande] ; Mari Lynne Silverberg [États-Unis] ; Yakup Batlevi [États-Unis] ; Roni Shouval [États-Unis] ; Sean M. Devlin ; Connie Batlevi [États-Unis] ; Renier J. Brentjens [États-Unis] ; Parastoo B. Dahi [États-Unis] ; Claudia Diamonte [États-Unis] ; Sergio Giralt [États-Unis] ; Elizabeth F. Halton [États-Unis] ; Molly Maloy [États-Unis] ; Maria Lia Palomba [États-Unis] ; Miriam Sanchez-Escamilla [États-Unis, Espagne] ; Craig S. Sauter [États-Unis] ; Michael Scordo [États-Unis] ; Gunjan Shah [États-Unis] ; Jae H. Park [États-Unis] ; Miguel-Angel Perales [États-Unis] | Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management |
| 000493 (2020) |
Alessandro Allegra ; Caterina Musolino ; Alessandro Tonacci ; Giovanni Pioggia ; Marco Casciaro ; Sebastiano Gangemi | Clinico-Biological Implications of Modified Levels of Cytokines in Chronic Lymphocytic Leukemia: A Possible Therapeutic Role |
| 000497 (2020) |
Satoshi Tsukuda [Japon] ; Tsukasa Ikeura [Japon] ; Takashi Ito [Japon] ; Koh Nakamaru [Japon] ; Masataka Masuda [Japon] ; Yuichi Hori [Japon] ; Manami Ikemune [Japon] ; Masato Yanagawa [Japon] ; Toshihiro Tanaka [Japon] ; Takashi Tomiyama [Japon] ; Takashi Yamaguchi [Japon] ; Yugo Ando [Japon] ; Kazushige Uchida [Japon] ; Toshiro Fukui [Japon] ; Akiyoshi Nishio [Japon] ; Rika Terasawa [Japon] ; Noboru Tanigawa [Japon] ; Kazuichi Okazaki [Japon] | Clinical implications of elevated serum interleukin-6 in IgG4-related disease |
| 000531 (2020) |
Xuetao Cao [République populaire de Chine] | COVID-19: immunopathology and its implications for therapy |
| 000552 (2020) |
Tomasz J. Guzik [Royaume-Uni] ; Saidi A. Mohiddin [Royaume-Uni] ; Anthony Dimarco [Royaume-Uni] ; Vimal Patel [Royaume-Uni] ; Kostas Savvatis [Royaume-Uni] ; Federica M. Marelli-Berg [Royaume-Uni] ; Meena S. Madhur [États-Unis] ; Maciej Tomaszewski [Royaume-Uni] ; Pasquale Maffia [Royaume-Uni] ; Fulvio D'Acquisto [Royaume-Uni] ; Stuart A. Nicklin [Royaume-Uni] ; Ali J. Marian [États-Unis] ; Ryszard Nosalski [Royaume-Uni] ; Eleanor C. Murray [Royaume-Uni] ; Bartlomiej Guzik [Pologne] ; Colin Berry [Royaume-Uni] ; Rhian M. Touyz [Royaume-Uni] ; Reinhold Kreutz [Allemagne] ; Dao Wen Wang [République populaire de Chine] ; David Bhella [Royaume-Uni] ; Orlando Sagliocco [Italie] ; Filippo Crea [Italie] ; Emma C. Thomson [Royaume-Uni] ; Iain B. Mcinnes [Royaume-Uni] | COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "implications"
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i \
-Sk "implications" \
| HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TocilizumabV1
|flux= 2020
|étape= Analysis
|type= indexItem
|index= AbsEn.i
|clé= implications
}}
| This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021 |  |
